JQ1 was shown to have a beneficial effect on the severity of the classical, Th17‐dependent and non‐B‐dependent experimental autoimmune encephalomyelitis (EAE) induced with the immunodominant peptide of myelin oligodendrocyte glycoprotein (MOG).17 Here, OMG is linked to experimental autoimmune encephalomyelitis.